Page last updated: 2024-08-23

epirubicin and Heart Failure

epirubicin has been researched along with Heart Failure in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (12.00)	18.7374
1990's	14 (28.00)	18.2507
2000's	14 (28.00)	29.6817
2010's	15 (30.00)	24.3611
2020's	1 (2.00)	2.80

Authors

Authors	Studies
Anzai, T; Chiba, Y; Fukushima, A; Ishizaka, S; Iwano, H; Kadosaka, T; Kamada, R; Kamiya, K; Koizumi, T; Konishi, T; Koya, T; Mizuguchi, Y; Motoi, K; Nagai, T; Omote, K; Oshino, T; Sarashina, M; Sato, T; Tada, A; Takenaka, S; Temma, T; Tsujinaga, S; Yamashita, H	1
Andersen, M; Banke, A; Bernsdorf, M; Ejlertsen, B; Fosbøl, EL; Gislason, GH; Jensen, MB; Møller, JE; Schou, M	1
Butler, J; Mahmood, SS; Patel, RB; Vaduganathan, M	1
Banke, A; Cold, S; Dahl, JS; Ewertz, M; Fosbøl, EL; Gislason, GH; Jensen, MB; Møller, JE; Poulsen, MK; Schou, M; Videbæk, L	1
Campone, M; Citron, ML; Dang, CT; Dirix, L; Gianni, L; Krop, IE; Romieu, G; Smitt, M; Suter, TM; Xu, N; Zamagni, C	1
Dieudonné, AS; Hatse, S; Lambrechts, D; Maggen, C; Neven, P; Paridaens, R; Pettengell, R; Pfeil, AM; Schwenkglenks, M; Szucs, TD; Vulsteke, C; Wildiers, H	1
Kang, MH; Lee, YR; Park, HM	1
Arai, M; Horiguchi, J; Koitabashi, N; Kurabayashi, M; Ohyama, Y; Rokutanda, N; Tateno, R	1
Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A	1
Hershman, DL; Neugut, AI	1
Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T	1
Bosso, G; Ceste, M; de Conciliis, E; Ferrero, G; Ferro, S; Giaretto, L; Lanfranco, C; Manfredi, R; Miglietta, L; Milanese, S; Parello, G; Simoni, C; Testore, F	1
Leonard, RC; Levine, AM; Oliveros, S; Tulpule, A; Williams, S	1
Appel, JM; Jensen, BV; Nielsen, DL; Ryberg, M; Zerahn, B	1
Baur, LH	1
Albrile, F; Biggi, A; Bobbio, M; Feola, M; Francini, A; Garrone, O; Merlano, M; Occelli, M; Visconti, G	1
Arnold, I; Shipman, KE	1
Cunningham, D; Hawkes, EA; Okines, AF; Plummer, C	1
Kanbayashi, C; Kawasaki, T; Okura, Y; Sato, N	1
Appel, JM; Christensen, HM; Ejlertsen, B; Fogh-Andersen, N; Jensen, BV; Møller, S; Nielsen, DL; Søgaard, P; Zerahn, B	1
Gradishar, WJ; Kaklamani, VG	1
Aldrighetti, D; Baldini, E; Bolognesi, A; Bruzzi, P; Carnino, F; Conte, PF; Gallo, L; Giannessi, P; Orlandini, C; Prochilo, T; Rosso, R; Salvadori, B; Venturini, M	1
Barats, JC; Bonneterre, J; Chapelle-Marcillac, I; Clavère, P; Datchary, J; Fargeot, P; Fumoleau, P; Goudier, MJ; Kerbrat, P; Monnier, A; Montcuquet, P; Roché, H; Van Praagh, I; Veyret, C	1
Ventura, GJ	1
De Giorgi, U; Emiliani, E; Frassineti, L; Giannini, M; Giovannini, N; Kopf, B; Marangolo, M; Palazzi, S; Rosti, G; Zumaglini, F	1
Ishizaki, A; Kamisaka, K; Katayama, K; Negishi, T	1
Cadeddu, C; Deidda, M; Dessì, M; Madeddu, C; Mantovani, G; Massa, E; Mercuro, G; Piras, A; Serpe, R	1
Aitini, E; Bajetta, E; Biganzoli, L; Bochicchio, AM; Buzzoni, R; Comella, G; D'Aprile, M; Di Leo, A; Nolè, F; Veltri, E	1
Anderström, C; Eddeland, A; Folmerz, P; Hansson, R; Milles, S; Zachrisson, B	1
Berchem, GJ; Delagardelle, C; Dicato, M; Duhem, C; Hanfelt, J; Keipes, M; Ries, F	1
Baldini, E; Conte, PF; Da Prato, M; Gennari, A; Gentile, A; Michelotti, A; Salvadori, B; Salzano, E; Tibaldi, C	1
Colleoni, M; Manente, P; Nelli, P; Pancheri, F; Sgarbossa, G; Vicario, G	1
Cameron, CH; Geraghty, RF; Kelso, EJ; McDermott, BJ; Nicholls, DP; Silke, B	1
Dombernowsky, P; Hansen, J; Jensen, BV; Nielsen, D; Ryberg, M; Skovsgaard, T	1
Abraham, R; Basser, RL; Fox, RM; Green, MD; To, LB	1
Bramwell, V; Moran, LA; Seymour, L	1
Bengala, C; Bruzzi, P; Conte, PF; Danesi, R; Del Tacca, M; Donati, S; Gennari, A; Orlandini, C; Salvadori, B	1
Bengala, C; Carnino, F; Conte, P; Del Mastro, L; Gallo, L; Lionetto, R; Michelotti, A; Montanaro, E; Rosso, R; Tibaldi, C; Venturini, M	1
Angeletti, CA; Basolo, F; Bruno, J; Hardin, M; Macchiarini, P	1
Bonardi, G; Calciati, A; Donadio, M; Giaccone, G; Iberti, V	1
Franzen, D; Hilger, HH; Pöhler, E	1
Benjamin, RS; Chawla, SP; Ewer, MS; Fraschini, G; Hortobagyi, GN; Kau, SW; Yap, HY	1
Niu-Tian-de, GB; Shkhvatsabaia, LV; Valvere, VIu	1
Alcan, KE; Benua, RS; Graham, MC; Oliver, FH; Palestro, C; Robeson, W	1
Bonacina, E; Cattaneo, M; di Massino, UV; Fesslova, V; Figini, A; Galli, MA; Jankovic, M; Masera, G; Ottaviani, V; Uderzo, C	1
Björkman, S; Elisson, LO	1
Bombardieri, E; Buraggi, GL; Crippa, F; Villani, F	1

Reviews

3 review(s) available for epirubicin and Heart Failure

Article	Year
Improving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet). Breast (Edinburgh, Scotland), 2009, Volume: 18, Issue:4 Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Heart; Heart Failure; Humans; Liposomes; Receptor-Interacting Protein Serine-Threonine Kinase 2; Trastuzumab; Ventricular Function	2009
Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? Clinical breast cancer, 2003, Volume: 4 Suppl 1 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Heart; Heart Failure; Humans; Quality of Life; Randomized Controlled Trials as Topic; Survival Analysis; United States	2003
Cardiac relapses in myeloid leukemia: case report and review of the literature. Pediatric hematology and oncology, 1987, Volume: 4, Issue:3 Topics: Cardiomyopathies; Child; Doxorubicin; Epirubicin; Female; Heart Failure; Heart Neoplasms; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mastoiditis; Myocardium; Skull Neoplasms	1987

Trials

19 trial(s) available for epirubicin and Heart Failure

Article	Year
Long-term effect of epirubicin on incidence of heart failure in women with breast cancer: insight from a randomized clinical trial. European journal of heart failure, 2018, Volume: 20, Issue:10 Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Denmark; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Forecasting; Heart Failure; Humans; Incidence; Middle Aged; Retrospective Studies; Risk Factors; Survival Rate	2018
Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Apr-01, Volume: 33, Issue:10 Topics: Adolescent; Adult; Aged; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Feasibility Studies; Fluorouracil; Headache; Heart Failure; Humans; Maytansine; Middle Aged; Nausea; Neoplasm Staging; Receptor, ErbB-2; Trastuzumab; Treatment Outcome; Young Adult	2015
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:17 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left	2015
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. International journal of cardiology, 2011, Apr-14, Volume: 148, Issue:2 Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Stroke Volume; Troponin I; Ventricular Dysfunction, Left	2011
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety. British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Heart Failure; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Risk Factors; Ventricular Dysfunction, Left	2004
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart; Heart Failure; Humans; Lymphatic Metastasis; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Dysfunction, Left	2004
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer. International journal of radiation oncology, biology, physics, 2006, Jul-15, Volume: 65, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Epirubicin; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Heart Failure; Humans; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiation Pneumonitis; Radiodermatitis; Razoxane; Recombinant Proteins	2006
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers. The oncologist, 2007, Volume: 12, Issue:9 Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers; Creatine Kinase; Echocardiography, Doppler; Epirubicin; Female; Glutathione Peroxidase; Heart Failure; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Contraction; Myoglobin; Natriuretic Peptide, Brain; Oxidative Stress; Reactive Oxygen Species; Receptors, Interleukin-6; Stroke Volume; Troponin I; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Septum	2007
Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group. American journal of clinical oncology, 1995, Volume: 18, Issue:3 Topics: Aged; Ambulatory Care; Bone Neoplasms; Drug Synergism; Drug Therapy, Combination; Epirubicin; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Survival Analysis	1995
Epirubicin and medroxyprogesterone acetate versus estramustine phosphate in hormone-resistant prostatic cancer: a prospective randomized study. European urology, 1995, Volume: 27, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Estramustine; Heart Failure; Humans; Male; Medroxyprogesterone Acetate; Prospective Studies; Prostatic Neoplasms; Recurrence	1995
A dose-finding study of epirubicin in combination with paclitaxel in the treatment of advanced breast cancer. Seminars in oncology, 1996, Volume: 23, Issue:5 Suppl 11 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Drug Tolerance; Epirubicin; Feasibility Studies; Female; Fever; Filgrastim; Granulocyte Colony-Stimulating Factor; Heart; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Peripheral Nervous System Diseases; Recombinant Proteins; Remission Induction; Stroke Volume; Ventricular Function, Left	1996
Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:1 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Heart Failure; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Stroke Volume; Survival Rate	1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Echocardiography; Epirubicin; Female; Heart Failure; Humans; Life Tables; Middle Aged; Paclitaxel; Risk Factors; Ventricular Function, Left	1999
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients. Breast cancer research and treatment, 2000, Volume: 59, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiovascular Agents; Epirubicin; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Razoxane; Treatment Outcome; Ventricular Dysfunction, Left	2000
Adjuvant chemotherapy for T1-2NOMO small cell lung cancer: single-agent or combination chemotherapy? Cancer investigation, 1991, Volume: 9, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Vomiting	1991
4'-EPI-doxorubicin in advanced lung cancer. A phase II trial. Investigational new drugs, 1990, Volume: 8, Issue:4 Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Evaluation; Drugs, Investigational; Epirubicin; Female; Heart Failure; Humans; Lung Neoplasms; Male; Middle Aged	1990
A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2 Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Heart Failure; Hematologic Diseases; Humans; Middle Aged; Nausea; Prospective Studies; Survival Rate	1991
A comparative study of doxorubicin and epirubicin in patients with metastatic breast cancer. American journal of clinical oncology, 1989, Volume: 12, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Heart Failure; Humans; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Prospective Studies; Random Allocation; Risk Factors; Therapeutic Equivalency; Time Factors	1989
[Comparative evaluation of the cardiotoxic effects of antineoplastic antibiotics adriamycin and pharmorubicin]. Kardiologiia, 1989, Volume: 29, Issue:9 Topics: Adult; Arrhythmias, Cardiac; Breast Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Heart Failure; Heart Rate; Humans; Middle Aged; Myocardial Contraction	1989

Other Studies

28 other study(ies) available for epirubicin and Heart Failure

Article	Year
Reversible Cancer Therapeutics-related Cardiac Dysfunction Complicating Intra-cardiac Thrombi. Internal medicine (Tokyo, Japan), 2020, Sep-01, Volume: 59, Issue:17 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents; Bevacizumab; Breast Neoplasms; Epirubicin; Female; Heart Failure; Humans; Treatment Outcome	2020
Epirubicin and long-term heart failure risk in breast cancer survivors. European journal of heart failure, 2018, Volume: 20, Issue:10 Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cancer Survivors; Epirubicin; Female; Heart Failure; Humans; Incidence	2018
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab. JACC. Heart failure, 2019, Volume: 7, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiotoxicity; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Denmark; Docetaxel; Epirubicin; Female; Heart Failure; Humans; Incidence; Longitudinal Studies; Mastectomy, Segmental; Middle Aged; Receptor, ErbB-2; Retrospective Studies; Risk; Stroke Volume; Trastuzumab	2019
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast cancer research and treatment, 2015, Volume: 152, Issue:1 Topics: Adult; Aged; Alleles; Antibiotics, Antineoplastic; Biomarkers, Tumor; Breast Neoplasms; Cardiotoxicity; Epirubicin; Female; Genetic Predisposition to Disease; Genotype; Heart Failure; Humans; Middle Aged; Multidrug Resistance-Associated Protein 2; Neoplasm Grading; Neoplasm Staging; Polymorphism, Single Nucleotide; Stroke Volume; Young Adult	2015
Anthracycline-induced cardiomyopathy in a dog treated with epirubicin. The Canadian veterinary journal = La revue veterinaire canadienne, 2015, Volume: 56, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Dog Diseases; Dogs; Epirubicin; Heart Failure; Lymphoma; Male	2015
Reversible Cardiomyopathy After Epirubicin Administration. International heart journal, 2015, Volume: 56, Issue:4 Topics: Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Breast Neoplasms; Cardiomyopathies; Cardiotonic Agents; Diuretics; Dobutamine; Echocardiography; Electrocardiography; Epirubicin; Female; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Respiration, Artificial; Severity of Illness Index; Treatment Outcome	2015
Anthracycline cardiotoxicity: one size does not fit all! Journal of the National Cancer Institute, 2008, Aug-06, Volume: 100, Issue:15 Topics: Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Heart Failure; Humans; Medicare; Predictive Value of Tests; Quality of Life; Risk Factors; SEER Program; United States	2008
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. Journal of the National Cancer Institute, 2008, Aug-06, Volume: 100, Issue:15 Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine	2008
Cardioprotective effect of dexrazoxane in patients with breast cancer treated with anthracyclines in adjuvant setting: a 10-year single institution experience. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2008, Volume: 8, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiovascular Agents; Dose-Response Relationship, Drug; Doxorubicin; Electrocardiography; Epirubicin; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Life Expectancy; Middle Aged; Neoplasm Metastasis; Razoxane; Retrospective Studies	2008
Systolic versus diastolic cardiac function variables during epirubicin treatment for breast cancer. The international journal of cardiovascular imaging, 2010, Volume: 26, Issue:2 Topics: Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Chi-Square Distribution; Diastole; Dose-Response Relationship, Drug; Epirubicin; Female; Gated Blood-Pool Imaging; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Proportional Hazards Models; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Systole; Time Factors; Ventricular Function, Left	2010
Close cardiac surveillance of patients treated with anthracyclines, also necessary after chemotherapy? The international journal of cardiovascular imaging, 2010, Volume: 26, Issue:2 Topics: Antibiotics, Antineoplastic; Blood Pressure; Breast Neoplasms; Diastole; Dose-Response Relationship, Drug; Epirubicin; Female; Gated Blood-Pool Imaging; Heart Failure; Heart Ventricles; Humans; Risk Assessment; Risk Factors; Systole; Time Factors; Ventricular Function, Left	2010
Case of epirubicin-induced cardiomyopathy in familial cardiomyopathy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18 Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Myosins; Cardiomegaly; Cardiomyopathy, Dilated; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Death, Sudden, Cardiac; Dothiepin; Dyspnea; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Male; Mastectomy, Segmental; Middle Aged; Migraine Disorders; Mutation, Missense; Myosin Heavy Chains; Point Mutation; Radiotherapy, Adjuvant	2011
Cardiotoxicity in patients treated with bevacizumab is potentially reversible. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Labeling; Early Termination of Clinical Trials; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Lymphoma, Large B-Cell, Diffuse; Meta-Analysis as Topic; Paclitaxel; Prednisone; Razoxane; Remission, Spontaneous; Rituximab; Trastuzumab; Vincristine	2011
A case of epirubicin-associated cardiotoxicity progressing to life-threatening heart failure and splenic thromboembolism. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:11 Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Epirubicin; Female; Fibrin Fibrinogen Degradation Products; Heart Failure; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Spleen; Thromboembolism; Troponin T	2012
Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Denmark; Drug Administration Schedule; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Radionuclide Ventriculography; Registries; Stroke Volume; Time Factors	2012
Liposomal doxorubicin in breast cancer: new preparation. Much ado about nothing. Prescrire international, 2003, Volume: 12, Issue:65 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Costs; Epirubicin; Female; France; Heart; Heart Failure; Humans; Treatment Outcome	2003
Doxorubicin liposomal pegylated: new preparation. Breast cancer: not just a question of short-term cardiac effects. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Approval; Drug Costs; Epirubicin; Europe; Female; Heart; Heart Failure; Humans; Treatment Outcome	2004
Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-20, Volume: 23, Issue:12 Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Drug Costs; Drug Industry; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans	2005
[Two cases with have a complication in cardiac function during chemotherapy with trastuzumab]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:4 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Echocardiography; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Middle Aged; Receptor, ErbB-2; Trastuzumab	2007
Epirubicin cardiotoxicity: a study comparing low- with high-dose-intensity weekly schedules. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1996, Volume: 4, Issue:4 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Heart Failure; Humans; Incidence; Male; Middle Aged; Neoplasms; Stroke Volume	1996
Feasibility of paclitaxel in a patient with anthracycline-induced congestive heart failure. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:2 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Epirubicin; Female; Heart Failure; Humans; Middle Aged; Paclitaxel	1997
Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:12 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Electrophysiology; Epirubicin; Heart; Heart Failure; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Myocardium; Rabbits	1997
Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:11 Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Heart Failure; Humans; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Risk Factors; Time Factors	1998
Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group. Cancer prevention & control : CPC = Prevention & controle en cancerologie : PCC, 1999, Volume: 3, Issue:2 Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cardiovascular Agents; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Epirubicin; Evidence-Based Medicine; Female; Heart; Heart Failure; Humans; Neoplasms; Odds Ratio; Randomized Controlled Trials as Topic; Razoxane; Time Factors; Treatment Outcome	1999
[Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide]. Medizinische Klinik (Munich, Germany : 1983), 1990, Volume: 85 Suppl 1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Epirubicin; Female; Heart Failure; Humans; Ifosfamide; Mastectomy, Segmental; Respiratory Insufficiency	1990
Early detection of anthracycline-induced cardiotoxicity by stress radionuclide cineangiography in conjunction with Fourier amplitude and phase analysis. Clinical nuclear medicine, 1985, Volume: 10, Issue:3 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cardiomyopathy, Dilated; Daunorubicin; Doxorubicin; Electrocardiography; Epirubicin; Female; Fourier Analysis; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Radionuclide Imaging; Sodium Pertechnetate Tc 99m	1985
Congestive heart failure in rabbits after a single intrapleural administration of a low dose of doxorubicin or epirubicin. Pharmacology & toxicology, 1988, Volume: 62, Issue:2 Topics: Animals; Body Weight; Doxorubicin; Epirubicin; Female; Heart Failure; Injections; Male; Pleura; Rabbits	1988
Adriamycin and epirubicin treatment monitored by radionuclide ejection fraction during therapy and follow-up. Tumori, 1985, Oct-31, Volume: 71, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Heart; Heart Failure; Humans; Middle Aged; Monitoring, Physiologic; Stroke Volume; Technetium	1985